Genetic mutations interact intricately to drive the development of skin cancer (e.g., A. PTCH1, CDKN2A, BRAF, TP53, and epigenetic modifications), as well as environmental elements like UV rays, persistent inflammation, and immunosuppression. This evidence concerns the gene BRAF and skin neoplasm.